Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer

Thorax

Volumn 63, Issue 4, 2008, Pages 342-344

  Targowski, T ^a   Jahnz Rozyk K ^a   Szkoda, T ^b   From, S ^a   Qandil, N ^c   Plusa T ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

^c Mazovian Centre of Tuberculosis and Lung Diseases   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TELOMERASE;

ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG INFILTRATE; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TRANSTHORACIC ASPIRATION;

BIOPSY, FINE-NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUNG; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 41849110973     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2007.083352     Document Type: Article

References (20)

1. Westcott JL. Percutaneous transthoracic needle biopsy. Radiology 1988;169:593.
2. Lacasse Y, Plante J, Martel S, et al. Transthoracic needle biopsy in the diagnosis of solitary pulmonary nodules: a survey of Canadian physicians. J Thorac Cardiovasc Surg 2003;126:761-8.
3. Kandallu K, Grant TH, Stull MA, et al. Percutaneous needle biopsy of mediastinal and pulmonary masses with a CT-guided extrapleural approach. Radiology 1996;201:270.
4. Gudmundsdottir A, Reynisson K, Gudmundsson G. Computerized tomography guided percutaneous needle biopsies at Lanspitali University Hospital. Indications, complications and result. Laeknabladid 2005;91:917-21.
5. Ohno Y, Hatabu H, Takenaka D, et al. CT-guided transthoracic needle aspiration biopsy of small (≤ 20 mm) solitary pulmonary nodules. AJR 2003;180:1665-9.
6. Olszewski W. Aspiration biopsy of intrathoracic lesions. Curr Diagn Pathol 1995;2:146-52.
7. Wojtas G, Jahnz-Różyk K, Płusa T, et al. [Freguency of complications after transthoracic fine-needle biopsy of lung tumors]. Pol Merk Lek 2001;11:314-9.
8. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
9. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
10. Anon. Telo TAGGG Telomerase PCR ELISAPLUS. Photometric enzyme immunoassay for quantitative determination of telomerase activity, utilizing the telomeric repeat amplification protocol (TRAP). Instruction manual. Mannheim, Germany: Roche Diagnostics, 1999.
11. Swensen JS, Jett JR, Hartman TE, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226:756- 61.
12. Larsheid RC, Thorpe PE, Scott WJ. Percutaneous transthoracic needle aspiration biopsy: a comprehensive review of its current role in the diagnosis and treatment of lung tumors. Chest 1998;114:704-9.
13. Sobolewski M, Włodarczyk R, Wojtas G, et al. [Fine needle biopsy in diagnosis of lung tumors]. Pol Merk Lek 1999;7:105-6.
14. Hiyama K, Ishioka S, Shay JW, et al. Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases. Int J Mol Med 1998;1:545-9.
15. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblast. Nature 1990;345:458-60.
16. Shammas MA, Koley H, Beer DG, et al. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. Gastroenterology 2004;126:1337-46.
17. Hiyama E, Saeki T, Hiyama K, et al. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer 2000;90:235-8.
18. Jin S, Zhang W, Teng M, et al. Significance of telomerase activity detection by fine-needle aspiration in patients with breast cancer (abstract in English). Zhonghua Bing Li Xue Za Zhi 1999;28:334-6.
19. Strauss GM, Kwiatkowski DJ, Harpole DH, et al. Molecular and pathologic markers in stage I non-small cell carcinoma of the lung. J Clin Oncol 1995;43:1269-79.
20. Taga S, Osaki T, Oghami A, et al. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg 1999;230:715-20.